van Rijk Anke, Mason David, Jones Margaret, Cabeçadas José, Crespo Mateus, Cigudosa Juan Cruz, Garcia Juan Fernando, Leoncini Lorenzo, Cocco Mario, Hansmann Martin-Leo, Mottok Anja, Copie Bergman Christiane, Baia Maryse, Anagnostou Dimitra, Pouliou Evi, Hamilton Dutoit Stephen, Hjøllund Christiansen Mette, Svenstrup Poulsen Tim, Hauge Matthiesen Steen, van Dongen Jacques, van Krieken J Han
Department of Pathology-824, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands,
J Hematop. 2008 Sep;1(2):119-26. doi: 10.1007/s12308-008-0017-5. Epub 2008 Aug 29.
Lymphomas originating from the lymphatic system comprise about 30 entities classified according to the World Health Organization (WHO). The histopathological diagnosis is generally considered difficult and prone to mistakes. Since non-random chromosomal translocations are specifically involved in different lymphoma entities, their detection will be increasingly important. Hence, a split-signal fluorescence in situ hybridisation (FISH) procedure would be helpful in discriminating the most difficult classifications. The Euro-FISH programme, a concerted action of nine European laboratories, has validated a robust, standardised protocol to improve the diagnostic approach on lymphoma entities. Therefore, 16 fluorescent probes and 10 WHO entities, supplemented with reactive cases, were selected. The results of the Euro-FISH programme show that all probes were correctly cytogenetically located, that the standardised protocol is robust, resulting in reliable results in approximately 90% of cases, and that the procedure could be implemented in every laboratory, bringing the relatively easy interpretation of split-signal probes within the reach of many pathology laboratories.
起源于淋巴系统的淋巴瘤包括约30种实体,这些实体是根据世界卫生组织(WHO)进行分类的。组织病理学诊断通常被认为具有难度且容易出错。由于非随机染色体易位特别涉及不同的淋巴瘤实体,对它们的检测将变得越来越重要。因此,一种分裂信号荧光原位杂交(FISH)程序将有助于区分最难的分类。欧洲FISH项目是九个欧洲实验室的一项协同行动,它已经验证了一个可靠的、标准化的方案,以改进对淋巴瘤实体的诊断方法。因此,选择了16种荧光探针和10个WHO实体,并补充了反应性病例。欧洲FISH项目的结果表明,所有探针在细胞遗传学上的定位都是正确的,标准化方案是可靠的,在大约90%的病例中能产生可靠的结果,并且该程序可以在每个实验室实施,使许多病理实验室都能够相对轻松地解读分裂信号探针。